Company | Mastercard Incorporated |
Ticker | MA |
Reporting Period | Q2 2026 (fiscal quarter ending June 30, 2026) |
Expected Earnings Date | Late July 2026 (exact date TBD; conference call announced) |
Last Earnings Date | April 30, 2026 (Q1 2026) |
Preparation Date | July 29, 2026 |
Sector ETF | XLF (Financial Select Sector SPDR) |
Key Takeaway: Setup is constructive — consensus sits at the low end of management's own guidance range, peer data from Visa and Amex confirm accelerating spend and cross-border recovery, and the Middle East conflict headwind that spooked the market on the Q1 print appears to be fading; the biggest swing factor is whether cross-border travel volume has recovered enough in Q2 to push net revenue growth toward the high end of the low-double-digit guidance range.
Heading into Q2 2026, Mastercard's setup looks modestly favorable: management guided net revenue growth to the "low end of low-double-digits" on a currency-neutral basis, a deliberately conservative bar set against the backdrop of Middle East conflict-driven cross-border travel weakness that was most acute in April. Since then, CFO Sachin Mehra confirmed at the May 19 JP Morgan conference that trends through the first two weeks of May were "stable to slightly better" across all metrics, with April timing distortions from Ramadan/Easter reversing as expected — consistent with management's base case that conflict impacts would be most pronounced in Q2 before a progressive H2 recovery. Estimate revisions have been essentially flat since the Q1 print, with consensus net revenue for Q2 2026 at ~$9.08B (implying ~10.5% currency-neutral growth) sitting just inside the guidance range, leaving limited downside risk from a bar-setting perspective. The stock has recovered strongly since the Q1 earnings-day selloff — up ~12% since April 30 vs. ~2% for the S&P 500 — suggesting the market has already partially re-rated the Middle East headwind as transient, though the stock's outperformance means a clean beat is needed to sustain momentum. The key wildcard is the pace of cross-border travel recovery: Visa's fiscal Q3 (ending June 2026) showed travel-related cross-border volume up 10% with a FIFA World Cup boost in June, and Amex reported global travel bookings up 22% YoY — both pointing to a healthier-than-feared travel environment that could push MA's cross-border growth above the ~11% consensus estimate for Q2.
Key Takeaway: Consensus is a low bar relative to management's own guidance — Q2 net revenue consensus of ~$9.08B implies ~10.5% currency-neutral growth, sitting at the low end of the "low-double-digit" guidance range, leaving room for a beat.
KPI | Q1 2026 Actual (Last Qtr) | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change (Est.) | Q2 2026 Guidance | Consensus vs. Guidance |
Net Revenue ($B) | $8.40B | $8.13B | $9.08B | +11.7% | Low end of low-double-digits (CN, ex-inorganic) + ~1-2 ppt FX tailwind | ~At low end of range |
Net Revenue Growth (CN %) | 12% CN | 16% CN | ~10.5% CN | -5.5 ppt YoY | Low end of low-double-digits | At low end |
EPS — Diluted Operating ($) | $4.60 | $4.15 | $4.77 | +14.9% | No explicit EPS guidance | N/A |
Cross-Border Volume Growth (CN %) | 13% | 15% | ~10.9% | -4.1 ppt YoY | Implied deceleration from conflict; recovery assumed in H2 | Below prior-year pace; conflict drag |
Switched Transactions (B) | 43.8B | 43.5B | 47.7B | +9.7% | No explicit guidance | N/A |
VASS Net Revenue ($B) | $3.45B | $3.19B | $3.74B | +17.2% | No explicit guidance; organic growth ~18% in Q1 | N/A |
Operating Income — Operating ($B) | $5.11B | $4.87B | $5.47B | +12.3% | Opex growth: low end of low-double-digits (CN) | Consistent with guidance |
Rebates & Incentives ($B) | -$5.64B | -$4.92B | -$5.75B | +16.8% YoY | Slightly lower sequentially vs. Q1 as % of assessments | Slight sequential improvement |
Source: Visible Alpha Consensus and Actuals Data. Q2 2026 Consensus as of July 29, 2026. CN = currency-neutral, ex-inorganic. VASS = Value-Added Services & Solutions.
KPI 1: Net Revenue (Reported, $B)
Quarter | Reported ($B) | Consensus ($B) | Surprise % | Result |
Q2 2024 | $6.96B | $6.85B | +1.6% | Beat |
Q3 2024 | $7.37B | $7.26B | +1.5% | Beat |
Q4 2024 | $7.49B | $7.39B | +1.4% | Beat |
Q1 2025 | $7.25B | $7.12B | +1.8% | Beat |
Q2 2025 | $8.13B | $7.97B | +2.0% | Beat |
Q3 2025 | $8.60B | $8.53B | +0.8% | Beat |
Q4 2025 | $8.81B | $8.77B | +0.4% | Beat |
Q1 2026 | $8.40B | $8.25B | +1.8% | Beat |
KPI 2: EPS — Diluted Operating ($)
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q2 2024 | $3.59 | $3.52 | +2.0% | Beat |
Q3 2024 | $3.88 | $3.73 | +4.0% | Beat |
Q4 2024 | $3.82 | $3.70 | +3.2% | Beat |
Q1 2025 | $3.73 | $3.57 | +4.5% | Beat |
Q2 2025 | $4.15 | $4.03 | +3.0% | Beat |
Q3 2025 | $4.38 | $4.32 | +1.4% | Beat |
Q4 2025 | $4.76 | $4.23 | +12.5% | Beat |
Q1 2026 | $4.60 | $4.40 | +4.5% | Beat |
Pattern: MA has beaten consensus on both net revenue and operating EPS in each of the last 8 consecutive quarters, with revenue beats averaging ~1.4% and EPS beats averaging ~4.4% — a consistent track record that sets a high bar for the market's reaction but also suggests the street has historically been too conservative. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Consensus is a
Key Takeaway: Consensus represents a
Key Takeaway: No guidance changes since the April 30 Q1 earnings call. Management tone at May and June conferences was consistently constructive — CFO Mehra confirmed trends were "stable to slightly better" through mid-May, and CEO Miebach reiterated healthy consumer spending at Bernstein on May 28. The full-year bar remains at the high end of low-double-digits CN, implying H2 acceleration that is more back-end loaded into Q4.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 30) | Revised Guidance | Current Consensus | Note |
Q2 2026 Net Revenue Growth (CN, ex-inorganic) | Low end of low-double-digits; ~1-2 ppt FX tailwind | — | ~10.5% CN (VA consensus) | Unchanged. Conflict impact most pronounced in Q2; without conflict, growth would have been in line with Q1 (12% CN). CFO confirmed mid-May trends stable to slightly better. |
FY 2026 Net Revenue Growth (CN, ex-inorganic) | High end of low-double-digits; ~1.5 ppt FX tailwind | — | ~11.9% CN (VA consensus) | Unchanged on CN basis. FX assumption improved slightly vs. prior guide. H2 acceleration more back-end loaded into Q4. |
Q2 2026 Opex Growth (CN, ex-inorganic) | Low end of low-double-digits; 0-1 ppt benefit from disposition; 0-1 ppt FX headwind | — | Consistent with guidance | Unchanged. SessionM disposition expected to close within Q2. |
FY 2026 Opex Growth (CN, ex-inorganic) | Low-double-digit range; 0.5-1 ppt tailwind from disposition; 0.5-1 ppt FX headwind | — | Consistent with guidance | Unchanged. |
Q2 & FY 2026 Non-GAAP Tax Rate | 20%-21% | — | Consistent with guidance | Unchanged. Q1 was lower due to discrete tax benefits (share-based payments) not expected to repeat. |
Q2 Other Income/Expense | ~$150M expense (ex-equity investment gains/losses) | — | N/A | Higher sequentially vs. Q1 due to lower cash balances, higher debt (accelerated buybacks), and one-time disposition impact. |
Rebates & Incentives (Q2 vs. Q1) | Slightly lower sequentially as % of payment network assessments | — | Consensus: -$5.75B | Unchanged. Slight sequential improvement expected. |
Key Takeaway: Guidance has been unchanged since the Q1 print — management held the full-year bar at the high end of low-double-digits CN and set Q2 at the low end, with no post-earnings revisions; tone at subsequent conferences has been
Key Takeaway: No guidance changes since the April 30 Q1 earnings call; management tone at May and June conferences was
Key Takeaway: Guidance is unchanged since the Q1 print. Management tone at May/June conferences was
Key Takeaway: Estimates have been essentially flat since the Q1 print — Q2 2026 net revenue consensus moved only ~$0.05B higher (+0.5%) and EPS moved ~$0.01 higher since the post-Q1 baseline, suggesting the street has largely accepted management's guidance without material upward or downward revision. The gap between consensus and the high end of guidance represents upside optionality if cross-border travel recovers faster than feared.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 5, 2026) | Current Consensus (Jul 29, 2026) | Estimate Delta (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance | Guidance Delta | Consensus vs. Guidance (%) |
Net Revenue — Q2 2026 | $9.07B | $9.08B | +0.1% | Low end of low-double-digits CN + ~1-2 ppt FX | Unchanged | — | At low end of range |
Net Revenue — FY 2026 | $37.12B | $37.13B | +0.0% | High end of low-double-digits CN + ~1.5 ppt FX | Unchanged | — | Consistent with high end |
EPS (Diluted Operating) — Q2 2026 | $4.76 | $4.77 | +0.2% | No explicit guidance | No explicit guidance | — | N/A |
EPS (Diluted Operating) — FY 2026 | $19.69 | $19.69 | 0.0% | No explicit guidance | No explicit guidance | — | N/A |
Cross-Border Volume Growth (CN %) — Q2 2026 | ~10.4% | ~10.9% | +0.5 ppt | Implied deceleration from conflict | Unchanged | — | Slight upward drift; Visa/Amex data supportive |
VASS Net Revenue — Q2 2026 | $3.62B | $3.74B | +3.3% | No explicit guidance; organic ~18% in Q1 | Unchanged | — | Upward revision; VASS demand remains strong |
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of May 5, 2026 (5 trading days after April 30 earnings). Current consensus as of July 29, 2026.
Estimates have barely moved since the Q1 print, reflecting the market's acceptance of management's guidance framework. The modest upward drift in VASS consensus (+3.3%) is the most notable revision, consistent with management's repeated emphasis on durable VASS demand and the virtuous cycle. Cross-border volume estimates have also ticked up slightly, likely reflecting Visa's strong Q3 cross-border data and Amex's travel commentary.
Key Takeaway: MA has outperformed meaningfully since the Q1 print (+12% vs. +2% for SPY), driven by the market re-rating the Middle East conflict headwind as transient and by strong peer data from Visa and Amex; the re-rating appears multiple-driven rather than estimate-driven, as consensus has barely moved, which means the stock needs a clean beat to sustain momentum at current levels.
MA vs. V (Peer) vs. XLF (Financials ETF) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings (April 30, 2026). Source: Stock Price Data.
Since the Q1 2026 earnings print on April 30, MA has recovered strongly from its initial ~3% selloff (driven by April cross-border travel deceleration data disclosed on the call). The stock is up ~12% since earnings vs. ~2% for the S&P 500 and ~9% for XLF, with Visa (V) tracking closely at ~12% — suggesting the outperformance is sector-driven by payments network re-rating rather than MA-specific alpha. Key events during the period: the May 7 leadership 8-K (CFO succession announcement) was absorbed without disruption; the May 19 JP Morgan conference provided the first post-earnings consumer spending update ("stable to slightly better") which helped stabilize the stock; the June 3 Evercore and June 9 RBC conferences reinforced the VASS and agentic commerce growth narrative. The stock's outperformance vs. SPY is almost entirely multiple expansion, as FY2026 EPS estimates have been flat at ~$19.69 since the Q1 print. At current levels (~$563), MA trades at approximately 29x FY2026 consensus EPS — a premium to historical averages but consistent with the VASS growth re-rating. The stock's strong run into earnings means the market needs a beat on cross-border volume and/or VASS to sustain the multiple.
Key Takeaway: Peer commentary from Q2 2026 earnings (Visa, Amex, Capital One, JPMorgan, BofA, Wells Fargo) is uniformly constructive for MA —
Key Takeaway: Peer Q2 2026 earnings commentary is uniformly constructive for MA: consumer spending is accelerating (not decelerating), cross-border volumes are recovering with travel up 10-12% at Visa and bookings up 22% at Amex, and credit quality remains pristine across the board — all pointing to a Q2 beat on both net revenue and cross-border volume.
Most relevant peer. Visa's fiscal Q3 (calendar Q2 2026) is the highest-quality read-through for MA's Q2 2026 print.
Strong affluent consumer read-through. AXP's premium cardholder base is directionally relevant for MA's cross-border travel and high-spend volume trends.
Key MA partner/customer. COF's Discover debit migration to its own network is now complete, but COF's consumer spending and credit data remain relevant for MA's domestic volume.
Overall Read-Through Assessment: The peer commentary is uniformly constructive for MA's Q2 2026 print. Consumer spending is accelerating (not decelerating), cross-border volumes are recovering with Visa's travel cross-border up 10% and Amex's travel bookings up 22%, credit quality is pristine, and the macro backdrop is described as "as good as it gets" by JPMorgan's CEO. The key risk — Middle East conflict impact on cross-border travel — appears to be fading faster than MA's conservative Q2 guidance assumed, with Amex explicitly noting "no evidence of a general slowdown" despite geopolitical impacts. This peer data collectively supports a beat on MA's Q2 cross-border volume and net revenue.
Key Takeaway: The most important development since Q1 earnings is the broad senior leadership reshuffle (effective August 3, 2026), which introduces execution risk around the CFO transition but was characterized by management as reflecting internal bench depth with no departures; the BVNK acquisition pending close and the stablecoin settlement expansion are the most strategically significant longer-term signals.
Key Takeaway: No open-market buys or discretionary sells from senior executives — all transactions since Q1 earnings are either 10b5-1 planned sales (pre-scheduled, non-discretionary) or routine stock option exercises paired with same-day sales, plus standard director equity award grants. Nothing signals unusual conviction or concern from insiders.
Name | Title | Transaction Type | Shares | Date | Note |
Arkell, Sandra A. | Controller | 10b5-1 Planned Sale | 144 / 200 / 200 / 200 shares (multiple tranches) | Jul 6-15, 2026 | Pre-scheduled 10b5-1 plan; routine, non-discretionary. |
McLaughlin, Edward G. | President & CTO, MA Tech | Option Exercise + Same-Day Sale (10b5-1) | 14,260 shares exercised & sold (Jul 1); 19,800 shares exercised (Jul 15) | Jul 1-15, 2026 | 10b5-1 plan. Option exercise paired with same-day sale is standard tax-efficient execution; not a discretionary sell signal. |
Seshadri, Raj | Chief Commercial Payments Officer | Option Exercise + Same-Day Sale (10b5-1) | ~6,805 shares across multiple tranches | Jul 1-2, 2026 | 10b5-1 plan. Seshadri recently transitioned to Senior Strategic Advisor role; sales consistent with pre-scheduled plan. |
Matsumoto, Oki | Director | Tax Withholding (F-code) | 98 shares | Jun 21, 2026 | Shares withheld for tax on RSU vesting; obligation-driven, not discretionary. |
Qureshi, Rima | Director | Tax Withholding (F-code) | 1,641 shares | Jun 16, 2026 | Shares withheld for tax on RSU vesting; obligation-driven, not discretionary. |
Multiple Directors (Bracher, Davis, Genachowski, Goh, Janow, Matsumoto, Moon, Sulzberger, Talwar, Uggla) | Directors | Equity Award Grant (A-code) | 509-684 shares each | Jun 16, 2026 | Annual director equity compensation grants; routine, non-discretionary. |
Source: SEC Form 4 filings. All transactions flagged as 10b5-1 plan (overall_10b5 = True) for executive officers. Director grants (A-code) are routine annual equity compensation. No open-market discretionary buys or sells from any senior executive or director since Q1 earnings. The absence of any open-market buying is not unusual given the stock's strong run (+12% since earnings) and the proximity to the earnings blackout window.
— End of Earnings Preview —
Disclaimer: This earnings preview is prepared for informational purposes only. All financial data sourced from Visible Alpha Consensus and Actuals Data, SEC Form 4 filings, and company earnings call transcripts. Consensus estimates as of July 29, 2026. Past beat/miss history is not indicative of future results. Stock price data sourced from Yahoo Finance.